UNSPSC 51132223: Acetaminophen/pyrilamine maleate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51132223 Acetaminophen/pyrilamine maleate is a Commodity code that in practice does not map to the recent state and local solicitations tagged under it. The three most recent opportunities posted under this code procure naloxone and drug deactivation systems, a therapeutic pharmacy initiative direct-to-manufacturer prescriptions program, and generic multi-source pharmaceuticals with over-the-counter products — none of which involve acetaminophen/pyrilamine maleate formulations. The code appears to be a miscategorization or a legacy tagging artifact in the sourcing jurisdictions' UNSPSC assignment workflows, and the recent activity provides no reliable signal about the actual demand for acetaminophen/pyrilamine maleate combinations at the state and local level.

State and local procurement activity under this code tag shows issuing bodies spanning county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across Minnesota and Oregon). The geographic spread includes Florida, Texas, Minnesota, and Oregon, with activity ranging from single-county IFB notices to multi-state cooperative RFP vehicles. Representative solicitations include Seminole County's IFB60459723LAS for naloxone and drug deactivation systems (IFB, due July 26, 2023), Texas HHS Commission's RFI HHS0017013 for direct-to-manufacturer prescription programs (RFI, due April 3, 2026), and MMCAP's S1070000015802 for generic pharmaceuticals and OTC products (RFP, due March 26, 2026). Because the recent opportunities do not align with the code's nominal scope, pursue this code only if you are already supplying acetaminophen/pyrilamine maleate formulations through existing state health department, county public health, or cooperative purchasing channels — otherwise the code shows no meaningful recent market activity in its stated category.